Zu J, Wang J, He Z, Zhao J, et al. Dapagliflozin improves diabetic retinopathy in mice by inhibiting LAMA1 and regulating the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 2025;782:152514.
PMID: 40925100